{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:36:16Z","timestamp":1786988176876,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ejso.2024.108593","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T08:38:13Z","timestamp":1723106293000},"page":"108593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Two-stage cytoreductive surgery for \u2018extensive\u2019 pseudomyxoma peritonei: A legitimate alternative or salvage strategy?"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6807-3271","authenticated-orcid":false,"given":"Swapnil","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9808-6898","authenticated-orcid":false,"given":"Aditi","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanket","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2471-0237","authenticated-orcid":false,"given":"A.S.","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejso.2024.108593_bib1","doi-asserted-by":"crossref","DOI":"10.1053\/ejso.2000.1038","article-title":"Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndrome","volume":"27","author":"Sugarbaker","year":"2001","journal-title":"Eur J Surg Oncol"},{"issue":"20","key":"10.1016\/j.ejso.2024.108593_bib2","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","article-title":"Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"30","author":"Chua","year":"2012","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108593_bib3","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.ejso.2020.11.138","article-title":"Outcomes in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for maximal volume (PCI 39) appendiceal tumours","volume":"47","author":"Sarkar","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.suronc.2019.03.004","article-title":"Survival after complete cytoreductive surgery and HIPEC for extensive pseudomyxoma peritonei","volume":"29","author":"Benhaim","year":"2019","journal-title":"Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108593_bib5","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1245\/s10434-009-0875-9","article-title":"Critical assessment of risk factors for complications after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"17","author":"Saxena","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2024.108593_bib6","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.ejso.2010.09.004","article-title":"Prospective longitudinal study of quality of life following cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"36","author":"Alves","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib7","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/jso.20253","article-title":"Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis","volume":"90","author":"Elias","year":"2005","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108593_bib8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1245\/s10434-010-1193-y","article-title":"Regarding \u201ctwo steps procedure for pseudomyxoma.\u201d","volume":"18","author":"Pocard","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib9","series-title":"Oxford textbook of fundamentals of surgery, oxford textbooks in surgery (oxford, 2016","article-title":"Principles of surgical oncology","author":"Gomez","year":"2016"},{"issue":"23","key":"10.1016\/j.ejso.2024.108593_bib10","doi-asserted-by":"crossref","first-page":"5965","DOI":"10.3390\/cancers13235965","article-title":"Novel perspectives in pseudomyxoma peritonei treatment","volume":"13","author":"Sommariva","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejso.2024.108593_bib11","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ejso.2012.07.009","article-title":"Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei","volume":"38","author":"Andreasson","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108593_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"PSOGI. Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108593_bib13","first-page":"23","article-title":"Results of two times-cytoreduction for patients with pseudomyxoma peritonei","volume":"2","author":"Yonemura","year":"2018","journal-title":"Pulsus J Surg Res"},{"issue":"5","key":"10.1016\/j.ejso.2024.108593_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1245\/s10434-019-07218-w","article-title":"Repeat cytoreductive surgery-hyperthermic intraperitoneal chemoperfusion is feasible and offers survival benefit in select patients with peritoneal metastases","volume":"26","author":"Choudry","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108593_bib15","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/02656736.2020.1772511","article-title":"Complete pathologic response after two-stage cytoreductive surgery with HIPEC for bulky pseudomyxoma peritonei: proof of concept","volume":"37","author":"Sgarbura","year":"2020","journal-title":"Int J Hyperther"},{"issue":"1","key":"10.1016\/j.ejso.2024.108593_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12957-021-02171-z","article-title":"Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index","volume":"19","author":"Trilling","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108593_bib17","first-page":"1","article-title":"Staged HIPEC may be feasible when it is not possible with the same setting of CRS","volume":"3","author":"Ray","year":"2021","journal-title":"J Can Res Rev Rep"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108593_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13193-019-00893-x","article-title":"History of peritoneal surface malignancy treatment in Japan","volume":"10","author":"Yonemura","year":"2019","journal-title":"Indian J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108593_bib19","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1245\/s10434-007-9701-4","article-title":"Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center","volume":"15","author":"Gusani","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108593_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10434-999-0582-6","article-title":"Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP)","volume":"6","author":"Park","year":"1999","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108593_bib21","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/SLA.0b013e3182263933","article-title":"Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis","volume":"254","author":"Quenet","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.108593_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.suronc.2018.11.006","article-title":"Long term survival analysis after hyperthermic intraperitoneal chemotherapy with oxaliplatin as a treatment for appendiceal peritoneal carcinomatosis","volume":"28","author":"Masckauchan","year":"2019","journal-title":"Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s12957-021-02276-5","article-title":"Feasibility and outcomes of cytoreductive surgery and HIPEC for peritoneal surface malignancies in low- and middle-income countries: a single-center experience of 232 cases","volume":"19","author":"Deo","year":"2021","journal-title":"World J Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108593_bib24","first-page":"99","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality","volume":"7","author":"Newton","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"4 Pt A","key":"10.1016\/j.ejso.2024.108593_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.ejso.2020.01.017","article-title":"Perioperative safety after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei from appendiceal origin: experience on 254 patients from a single center","volume":"46","author":"Li","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2024.108593_bib26","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1245\/s10434-015-5019-9","article-title":"Can a benefit be expected from surgical debulking of unresectable pseudomyxoma peritonei?","volume":"23","author":"Delhorme","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib27","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1002\/bjs.9674","article-title":"Multicentre study of the learning curve and surgical performance of cytoreductive surgery with intraperitoneal chemotherapy for pseudomyxoma peritonei","volume":"101","author":"Kusamura","year":"2014","journal-title":"Br J Surg"},{"issue":"8","key":"10.1016\/j.ejso.2024.108593_bib28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.ejso.2014.03.001","article-title":"Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve","volume":"40","author":"Andr\u00e9asson","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108593_bib29","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/jso.23231","article-title":"Learning curve for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal surface malignancies: analysis of two centres: cytoreductive Surgery and Learning Curve","volume":"107","author":"Kusamura","year":"2013","journal-title":"J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2024.108593_bib30","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.clon.2022.03.003","article-title":"Learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy - an analysis of critical perioperative and surgical outcomes among 155 peritoneal surface malignancy patients treated at a tertiary care cancer centre","volume":"34","author":"Saikia","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib31","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1245\/s10434-014-4111-x","article-title":"Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies","volume":"22","author":"Polanco","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib32","article-title":"Clinical outcomes of patients with extensive peritoneal carcinomatosis following cytoreductive surgery and perioperative intraperitoneal chemotherapy","author":"Huang","year":"2016","journal-title":"Anticancer Res"},{"issue":"9","key":"10.1016\/j.ejso.2024.108593_bib33","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/ans.15331","article-title":"Accelerating the learning curve in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using an external mentor model","volume":"89","author":"Ansari","year":"2019","journal-title":"ANZ J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2024.108593_bib34","article-title":"Case selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy; our experience from peritoneal MDT","volume":"46","author":"Sayyad","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2024.108593_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.877970","article-title":"The road to technical proficiency in cytoreductive surgery for peritoneal carcinomatosis: risk-adjusted cumulative summation analysis","volume":"9","author":"Santullo","year":"2022","journal-title":"Front. Surg."},{"issue":"10","key":"10.1016\/j.ejso.2024.108593_bib36","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/codi.14310","article-title":"Referral and treatment pathways for pseudomyxoma peritonei of appendiceal origin within a national treatment programme","volume":"20","author":"Fish","year":"2018","journal-title":"Colorectal Dis"},{"issue":"7","key":"10.1016\/j.ejso.2024.108593_bib37","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.ejso.2016.04.059","article-title":"Should total gastrectomy and total colectomy be considered for selected patients with severe tumor burden of pseudomyxoma peritonei in cytoreductive surgery?","volume":"42","author":"Liu","year":"2016","journal-title":"Eur J Surg Oncol"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108593_bib38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s13193-018-00870-w","article-title":"Analysis of clinical outcomes of pseudomyxoma peritonei from appendicular origin following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy-A retrospective study from INDEPSO","volume":"10","author":"Sinukumar","year":"2019","journal-title":"Indian J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108593_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/SLA.0b013e31820b4dba","article-title":"Upfront compared to delayed cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei is associated with considerably lower perioperative morbidity and recurrence rate","volume":"253","author":"Chua","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2024.108593_bib40","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/cam4.5138","article-title":"Survival prediction by Bayesian network modeling for pseudomyxoma peritonei after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy","volume":"12","author":"Zhao","year":"2023","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.ejso.2024.108593_bib41","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/oncolo\/oyac006","article-title":"Surrogacy beyond prognosis: the importance of \"Trial-Level\" surrogacy","volume":"27","author":"Buyse","year":"2022","journal-title":"Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2024.108593_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/jso.20038","article-title":"Clinically aggressive pseudomyxoma peritonei: a variant of a histologically indolent process","volume":"86","author":"Mohamed","year":"2004","journal-title":"J Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2024.108593_bib43","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jamcollsurg.2015.12.012","article-title":"Prognostic molecular subtypes of LowGrade cancer of the appendix","volume":"222","author":"Levine","year":"2016","journal-title":"J Am Coll Surg"},{"issue":"7","key":"10.1016\/j.ejso.2024.108593_bib44","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ejso.2018.03.032","article-title":"Can low grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification","volume":"44","author":"Bhatt","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2024.108593_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/his.13324","article-title":"The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei","volume":"71","author":"Carr","year":"2017","journal-title":"Histopathology"},{"issue":"Suppl 1","key":"10.1016\/j.ejso.2024.108593_bib46","doi-asserted-by":"crossref","first-page":"S216","DOI":"10.21037\/jgo-2020-01","article-title":"New insights in the pathology of peritoneal surface malignancy","volume":"12","author":"Carr","year":"2021","journal-title":"J Gastrointest Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2024.108593_bib47","doi-asserted-by":"crossref","first-page":"866","DOI":"10.4103\/ija.ija_367_23","article-title":"Impact of fluid and haemodynamic management in cytoreductive surgery with hyperthermic intraperitoneal chemotherapy on postoperative outcomes \u2013 a systematic review","volume":"67","author":"Solanki","year":"2023","journal-title":"Indian J Anaesth"},{"issue":"12","key":"10.1016\/j.ejso.2024.108593_bib48","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","article-title":"Guidelines for perioperative care in cytoreductive surgery (CRS) with or without hyperthermic IntraPEritoneal chemotherapy (HIPEC): enhanced recovery after surgery (ERAS\u00ae) society recommendations \u2014 Part I: preoperative and intraoperative management","volume":"46","author":"H\u00fcbner","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2024.108593_bib49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/pp-2021-0117","article-title":"Enhanced recovery after surgery (ERAS) in cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): a cross-sectional survey","volume":"6","author":"Bhandoria","year":"2021","journal-title":"Pleura and Peritoneum"},{"issue":"4","key":"10.1016\/j.ejso.2024.108593_bib50","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1097\/SLA.0000000000001723","article-title":"A perioperative clinical pathway can dramatically reduce failure-to-rescue rates after cytoreductive surgery for peritoneal carcinomatosis: a retrospective study of 666 consecutive cytoreductions","volume":"265","author":"Passot","year":"2017","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.ejso.2024.108593_bib51","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1463-1318.2009.01947.x","article-title":"Survival of patients with pseudomyxoma peritonei treated by serial debulking","volume":"12","author":"J\u00e4rvinen","year":"2010","journal-title":"Colorectal Dis"},{"issue":"9","key":"10.1016\/j.ejso.2024.108593_bib52","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1016\/j.ejso.2021.05.015","article-title":"Complete Cytoreductive Surgery vs. Debulking Surgery for pseudomyxoma peritonei of appendiceal origin: a propensity score-matched study based on a single-center experience","volume":"47","author":"Ma","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.ejso.2024.108593_bib53","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.ejso.2012.07.009","article-title":"Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei","volume":"38","author":"Andr\u00e9asson","year":"2012","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2024.108593_bib54","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1177\/1457496915598759","article-title":"Palliative surgery for pseudomyxoma peritonei","volume":"105","author":"Funder","year":"2016","journal-title":"Scand J Surg"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324006450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798324006450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T22:20:37Z","timestamp":1726784437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798324006450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":54,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0748798324006450"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108593","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Two-stage cytoreductive surgery for \u2018extensive\u2019 pseudomyxoma peritonei: A legitimate alternative or salvage strategy?","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2024.108593","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108593"}}